Fidia S.p.A. (BIT:FDA)
0.0094
+0.0014 (17.50%)
May 21, 2026, 1:38 PM CET
Fidia Revenue
Fidia had revenue of 13.59M EUR in the half year ending June 30, 2025, with 51.15% growth. This brings the company's revenue in the last twelve months to 21.13M, down -28.94% year-over-year. In the year 2024, Fidia had annual revenue of 17.53M, down -38.98%.
Revenue (ttm)
21.13M
Revenue Growth
-28.94%
P/S Ratio
0.01
Revenue / Employee
150.93K
Employees
140
Market Cap
165.20K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.53M | -11.20M | -38.98% |
| Dec 31, 2023 | 28.74M | 4.07M | 16.52% |
| Dec 31, 2022 | 24.66M | 485.00K | 2.01% |
| Dec 31, 2021 | 24.18M | 2.52M | 11.65% |
| Dec 31, 2020 | 21.65M | -24.55M | -53.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EuroGroup Laminations | 823.05M |
| Biesse | 654.66M |
| SIT S.p.A. | 321.40M |
| Tesmec | 262.17M |
| ILPRA | 86.63M |
| Clabo | 58.10M |
| Marzocchi Pompe | 37.47M |
| OSAI Automation System | 34.56M |
Fidia News
- 20 hours ago - 20k medical shops shut in Mumbai, 200 kept open for emergencies amid strike - The Times of India
- 21 hours ago - Guardant Health (GH) Shares Rise Following FDA Approval of Guardant360 Liquid CDx - GuruFocus
- 22 hours ago - My Top 3 Biotech Stocks for May 2026 - The Motley Fool
- 22 hours ago - Why ImmunityBio Stock is Soaring Higher Today - The Motley Fool
- 23 hours ago - ImmunityBio (IBRX) Gains 9% on FDA Acceptance of Anktiva Marketing Application - GuruFocus
- 23 hours ago - Guardant Health (GH) Gains FDA Approval for New Liquid Biopsy Test - GuruFocus
- 1 day ago - Guardant Health: FDA Approves Guardant360 Liquid CDx - Nasdaq
- 1 day ago - Lupin bets big on India's GLP-1 market & respiratory drugs - CNBC